Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_provenance.
- NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_assertion description "[Given that GDM women with persistent IGT are at a high risk of developing T2DM, understanding how the nutrient-sensitive mammalian target of rapamycin/S6K1 pathway is chronically activated in GDM may lead to important therapies that could prevent the progression to T2DM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_provenance.
- NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_assertion evidence source_evidence_literature NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_provenance.
- NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_assertion SIO_000772 21289241 NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_provenance.
- NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_assertion wasDerivedFrom befree-2016 NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_provenance.
- NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_assertion wasGeneratedBy ECO_0000203 NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_provenance.
- befree-2016 importedOn "2016-02-19" NP869790.RAkwOHH9uHSwWh7G93UnIq2EKcPtMsY75YsXbYnQGG0fc130_provenance.